Valuation: Progyny, Inc.

Capitalization 213.12Cr 183.11Cr 171.79Cr 160.07Cr 294.78Cr 19TCr 320.35Cr 1.99TCr 774.27Cr 9.08TCr 799.74Cr 782.79Cr 33TCr P/E ratio 2025 *
37.6x
P/E ratio 2026 * 25.8x
Enterprise value 199.76Cr 171.64Cr 161.02Cr 150.04Cr 276.31Cr 18TCr 300.28Cr 1.87TCr 725.76Cr 8.51TCr 749.63Cr 733.75Cr 31TCr EV / Sales 2025 *
1.57x
EV / Sales 2026 * 1.31x
Free-Float
76.13%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.08%
1 week-0.92%
Current month-6.26%
1 month+10.51%
3 months+7.62%
6 months+12.52%
Current year+43.30%
More quotes
1 week 23.75
Extreme 23.75
25.27
1 month 23.32
Extreme 23.315
27.51
Current year 17.01
Extreme 17.0076
27.51
1 year 13.86
Extreme 13.86
27.51
3 years 13.39
Extreme 13.39
44.95
5 years 13.39
Extreme 13.39
68.32
10 years 13.29
Extreme 13.29
68.32
More quotes
Manager TitleAgeSince
Chief Executive Officer 58 01/01/2022
President 48 01/01/2022
Director of Finance/CFO 59 15/09/2020
Director TitleAgeSince
Chairman 65 01/01/2022
Director/Board Member 50 16/12/2016
Director/Board Member 58 01/01/2022
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+0.08%-0.92%+56.06%-21.27% 213.12Cr
-0.01%-0.29%-42.28%-39.99% 29TCr
-0.24%-0.34%-16.64%-37.17% 7.33TCr
-0.31%-4.16%-17.68%-20.90% 7.02TCr
-2.34%+3.48%-12.52%-53.06% 3.01TCr
+0.53%-1.88%-34.89%-55.85% 1.87TCr
+0.88%+7.47%-48.82%-54.01% 806.36Cr
-0.77%+0.63%+68.07%+65.89% 384.38Cr
+1.17%+4.02%-21.52%+129.20% 133.82Cr
+3.82%+2.60%-20.76% - 40Cr
Average +0.27%+1.28%-9.10%-9.68% 5.01TCr
Weighted average by Cap. -0.23%-0.53%-31.79%-37.16%
See all sector performances

Financials

2025 *2026 *
Net sales 127.63Cr 109.66Cr 102.88Cr 96Cr 176.54Cr 11TCr 191.85Cr 1.19TCr 463.7Cr 5.44TCr 478.95Cr 468.8Cr 20TCr 139.76Cr 120.08Cr 112.66Cr 104.97Cr 193.32Cr 13TCr 210.09Cr 1.31TCr 507.76Cr 5.95TCr 524.46Cr 513.35Cr 22TCr
Net income 5.88Cr 5.06Cr 4.74Cr 4.42Cr 8.14Cr 528.66Cr 8.84Cr 55Cr 21Cr 250.58Cr 22Cr 22Cr 923.24Cr 8.46Cr 7.27Cr 6.82Cr 6.35Cr 12Cr 760.21Cr 13Cr 79Cr 31Cr 360.32Cr 32Cr 31Cr 1.33TCr
Net Debt -13Cr -11Cr -11Cr -10Cr -18Cr -1.2TCr -20Cr -124.82Cr -49Cr -568.67Cr -50Cr -49Cr -2.1TCr -30Cr -26Cr -24Cr -23Cr -42Cr -2.73TCr -46Cr -283.87Cr -110.33Cr -1.29TCr -113.96Cr -111.55Cr -4.77TCr
More financial data * Estimated data
Logo Progyny, Inc.
Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.4 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.
Employees
678
More about the company
Date Price Change Volume
09/25/09 24.72 $ +0.08% 9,99,252
08/25/08 24.70 $ +2.83% 12,55,514
05/25/05 24.02 $ -0.54% 12,53,179
04/25/04 24.15 $ -1.63% 11,54,607
03/25/03 24.55 $ -1.60% 10,50,998

Delayed Quote Nasdaq, December 10, 2025 at 02:30 am IST

More quotes
Trader
Investor
Global
Quality
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
24.72USD
Average target price
29.10USD
Spread / Average Target
+17.72%
Consensus

Quarterly revenue - Rate of surprise